Table 4 Joint effects of age and body fat distribution pattern on restrictive lung disease in women.

From: Gender- and Age-Specific Associations Between Body Fat Composition and C-Reactive Protein with Lung Function: A Cross-Sectional Study

 

Non-obese type

Non-visceral obesity type

Visceral obesity type

<45 y/o

No. of RLD/patient no. (%)

261/1952 (13.4%)

266/2843 (9.4%)

9/50 (18.0%)

OR and 95% CI

Model 1a

1 (reference)

0.67 (0.56–0.80)*

1.42 (0.68–2.96)

Model 2b

1 (reference)

0.77 (0.61–0.96)*

2.17 (0.94–5.02)

Model 3c

1 (reference)

0.76 (0.60–0.94)*

1.99 (0.85–4.63)

≥45 y/o

No. of RLD/patient no. (%)

77/579 (13.3)

354/2422 (14.6)

92/304 (30.3)

OR and 95% CI

Model 1a

1 (reference)

1.12 (0.86–1.45)

2.83 (2.01–3.99)*

Model 2b

1 (reference)

0.89 (0.67–1.19)

1.64 (1.06–2.54)*

Model 3c

1 (reference)

0.89 (0.67–1.19)

1.60 (1.03–2.49)*

  1. Nonobese type: BF% ≤ 27.
  2. Nonvisceral obesity type: BF% > 27 and visceral fat degree ≤10.
  3. Visceral obesity type: BF% > 27 and visceral fat degree >10.
  4. aModel 1, unadjusted analysis.
  5. bModel 2, adjusted for waist-to-height ratio and mean arterial pressure.
  6. cModel 3, Model 2+ fasting glucose level and hsCRP level.
  7. RLD, restrictive lung disease, OR: odds ratio, CI: confidence interval, BF%: body fat percentage, CRP: C-reactive protein.
  8. *Indicates P < 0.05.
Back to article page